Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease

Converging evidence from genetic, pathological and experimental studies have increasingly suggested an important role for autophagy impairment in Parkinson’s Disease (PD). Genetic studies have identified mutations in genes encoding for components of the autophagy-lysosomal pathway (ALP), including g...

Full description

Saved in:

Bibliographic Details
Published in:	Molecular neurodegeneration Vol. 12; no. 1; p. 11
Main Authors:	Moors, Tim E., Hoozemans, Jeroen J. M., Ingrassia, Angela, Beccari, Tommaso, Parnetti, Lucilla, Chartier-Harlin, Marie-Christine, van de Berg, Wilma D. J.
Format:	Journal Article
Language:	English
Published:	London BioMed Central 25.01.2017 BioMed Central Ltd Springer Nature B.V
Subjects:	Autophagy (Cytology) Biomedical and Life Sciences Biomedicine Care and treatment Dosage and administration Genetic aspects Health aspects Life Sciences Molecular Medicine Neurology Neurosciences Parkinson's disease Rapamycin Review Risk factors Autophagic Cell Death Dementia With Lewy Body Ambroxol Dementia With Lewy Body Patient Gauche Disease
ISSN:	1750-1326, 1750-1326
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!